why choose us

First received: June 28, 2023

Clinical Trial: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Study Status: Completed

Recruit Status: RECRUITING

Condition: Follicular Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Brief Summary: This is a clinical trial to evaluate the feasibility and safety of giving tazemetostat followed by standard of care CAR T cell infusion in previously treated diffuse large b-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma (MCL).The investigators hypothesis is that this combination has the potential to significantly improve the ability of CART cells to recognize and kill lymphoma cells without a significant impact on safety.Participants will receive the tazemetostat pills before and after…

Read more